Hayat Pharmaceutical Industries Co (AMM:HPIC) Total Assets: JOD38.68 Mil (As of Mar. 2026)


AMM:HPIC Hayat Pharmaceutical Industries Co AMM:HPIC
77 GF Score
Price JOD3.20
GF Value JOD2.74
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Hayat Pharmaceutical Industries Co Total Assets?

Hayat Pharmaceutical Industries Co AMM:HPIC 77 Total Assets is JOD38.68 Mil as of Mar. 2026. GuruFocus rates AMM:HPIC with a GF Score™ of 77/100 and a GF Value™ of JOD2.74 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Hayat Pharmaceutical Industries Co's Total Assets for the quarter that ended in Mar. 2026 was JOD38.68 Mil.

During the past 12 months, Hayat Pharmaceutical Industries Co's average Total Assets Growth Rate was -6.60% per year. During the past 3 years, the average Total Assets Growth Rate was 0.60% per year. During the past 5 years, the average Total Assets Growth Rate was 1.60% per year. During the past 10 years, the average Total Assets Growth Rate was 5.80% per year.

During the past 13 years, Hayat Pharmaceutical Industries Co's highest 3-Year average Total Assets Growth Rate was 15.50%. The lowest was 0.50%. And the median was 5.90%.

Total Assets is connected with ROA %. Hayat Pharmaceutical Industries Co's annualized ROA % for the quarter that ended in Mar. 2026 was 1.61%. Total Assets is also linked to Revenue through Asset Turnover. Hayat Pharmaceutical Industries Co's Asset Turnover for the quarter that ended in Mar. 2026 was 0.05.


Hayat Pharmaceutical Industries Co  (AMM:HPIC) Total Assets Explanation

Total Assets is connected with ROA %.

Hayat Pharmaceutical Industries Co's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0.612/( (37.422+38.675)/ 2 )
=0.612/38.0485
=1.61 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Hayat Pharmaceutical Industries Co's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=2.021/( (37.422+38.675)/ 2 )
=2.021/38.0485
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Hayat Pharmaceutical Industries Co Total Assets Related Terms


Hayat Pharmaceutical Industries Co Total Assets Historical Data

* Premium members only.

The historical data trend for Hayat Pharmaceutical Industries Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hayat Pharmaceutical Industries Co Total Assets Chart

Hayat Pharmaceutical Industries Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.04 34.01 34.40 37.50 37.42

Hayat Pharmaceutical Industries Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.52 36.45 38.17 37.42 38.68
AMM:HPIC
77GF Score
Hayat Pharmaceutical Industries Co AMM:HPIC
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hayat Pharmaceutical Industries Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Hayat Pharmaceutical Industries Co's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=31.063+6.36
=37.42

Hayat Pharmaceutical Industries Co's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=31.215+7.46
=38.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of JOD38.68 Mil mean?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a Total Assets of JOD38.68 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Hayat Pharmaceutical Industries Co and its competitors.
Is Hayat Pharmaceutical Industries Co's Total Assets too high?
Hayat Pharmaceutical Industries Co's current Total Assets is JOD38.68 Mil. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's Total Assets compare to ZTS and UTHR?
Hayat Pharmaceutical Industries Co's Total Assets of JOD38.68 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Hayat Pharmaceutical Industries Co and its competitors. Hayat Pharmaceutical Industries Co's current Total Assets is JOD38.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co (AMM:HPIC) is currently considered Modestly Overvalued. The stock's GF Value™ is JOD2.74, compared to a current price of JOD3.20 — trading 16.8% above its estimated fair value. The current Total Assets is JOD38.68 Mil. Hayat Pharmaceutical Industries Co's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current Total Assets is JOD38.68 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hayat Pharmaceutical Industries Co (AMM:HPIC) Overvalued in 2026?

Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co stock appears to be overvalued. The current stock price of JOD3.20 is trading 16.8% above its estimated GF Value™ of JOD2.74. GuruFocus considers Hayat Pharmaceutical Industries Co to be Modestly Overvalued.

Key valuation signals for AMM:HPIC:

  • Total Assets: JOD38.68 Mil
  • GF Value™: JOD2.74 vs. price of JOD3.20 (16.8% above fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the AMM:HPIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hayat Pharmaceutical Industries Co Business Description

Address Mohammed Ali Alkurdi St. Al-Rajeeb Amman, 1564 Amman, Amman, JOR, 11118
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
77GF Score

Get the complete analysis for AMM:HPIC

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD3.20
Price
JOD2.74
GF Value